Updated hourlyHourly refreshWed, Oct 28, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare · Education
MECHANICSBURG, Pa., August 17, 2026--The Global Vitiligo Foundation (GVF) proudly recognizes and supports Incyte’s Moments of Clarity campaign, a powerful storytelling initiative that highlights the lived experiences of individuals with nonsegmental vitiligo. Through authentic patient narratives, the campaign closely aligns with GVF’s mission to improve the quality of life for people affected by vitiligo through education, advocacy, and community connection.
Aug 17 · 15:14·Business Wire
Finance · Healthcare
ATLANTA, Aug. 17, 2026 -- A shareholder class action lawsuit has been filed against Aardvark Therapeutics, Inc. (“Aardvark”) (NASDAQ: AARD). The lawsuit alleges that Defendants, in Aardvark’s Registration Statement and throughout the Class Period, made false and misleading statements and/or failed to disclose material adverse facts, including allegations that: (i) ARD-101 was less safe than Defendants had led investors to believe; and (ii) accordingly, ARD-101’s clinical, regulatory, and commercial prospects were overstated.
Aug 17 · 15:02·GlobeNewswire
Healthcare · Biotech & pharma
Company announcement No. 40 / 2026
Aug 17 · 15:00·GlobeNewswire
Healthcare · Travel
Toronto, Ontario--(August 17, 2026) - MindSeed is highlighting its virtual model of mental health care, providing clients across Ontario with access to a centre of clinical excellence without requiring them to travel to a physical clinic.The MindSeed teamTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/11862/309771_d3f06c0804631ad1_001full.jpgBased in Toronto, MindSeed provides virtual therapy to clients across Ontario through a...
Aug 17 · 14:48·Newsfile
Finance · Healthcare
NORWOOD, Mass., Aug. 17, 2026 -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage company focused on new therapies in oncology and obesity, today announced the grant of inducement equity awards outside of the Company's stockholder-approved equity compensation plans to Leonardo Nicacio in connection with his commencement of employment as Chief Medical Officer of the Company. The grants were approved by the Compensation Committee of the Board of Directors effective as of August 16, 2026, as inducements material to Mr. Nicacio entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
Aug 17 · 14:00·GlobeNewswire
Healthcare · Biotech & pharma
Appointed Pharma Industry Veteran Brendan O’Grady as Chief Executive Officer
Aug 17 · 12:14·GlobeNewswire
SaaS · Healthcare
Both executives have worked alongside the company since last fall, shaping its technology and regulatory strategy through a period of sustained network growth. CORAL SPRINGS, Fla., Aug. 17, 2026 -- Health Gorilla, an interoperability platform powering nationwide health data...
Aug 17 · 12:11·PR Newswire
Healthcare · Education
Midwest retailer announces more options to meet customer vaccination needs heading into new school year and cold and flu season GRAND RAPIDS, Mich., Aug. 17, 2026 -- Meijer is helping more customers take charge of their health by making recommended vaccinations easier to...
Aug 17 · 12:09·PR Newswire
Finance · Healthcare
Online human performance company ranks No. 34 in Healthcare & Medical following 1,236% three-year revenue growth SCOTTSDALE, Ariz., Aug. 17, 2026 -- Supra Human, a leading human performance and transformation company founded by former NFL athlete John Madsen and former...
Aug 17 · 12:08·PR Newswire
Healthcare · Education
University of Miami medical oncology chief and Sylvester global oncology leader will guide scientific strategy, clinical evidence and the responsible advancement of Functional Precision Oncology MIAMI, Fla., Aug. 17, 2026 -- First Ascent Biomedical, a precision oncology...
Aug 17 · 12:04·PR Newswire
Healthcare · Biotech & pharma
The proposed proprietary name, or brand name, CIFBEZY has received conditional acceptance from the FDA and also federal trademark allowance from the USPTO These initial milestones will form the basis for the commercial identity of Acurx's lead product candidate, ibezapolstat, as the...
Aug 17 · 12:01·PR Newswire
Finance · Healthcare
CHICAGO, August 17, 2026--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management will be participating in the following investor conferences in September.
Aug 17 · 12:01·Business Wire